Central South University — CureCurrent

Published trials77

Recruiting shown13

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

tACS for Working Memory in SchizophreniaNCT07701343 · lead sponsor · 2026-07-06

TIS for Improving Cognitive Impairment in SchizophreniaNCT07647380 · lead sponsor · 2026-06-24

School and Family-Based Obesity Prevention in Pakistani Primary School ChildrenNCT07616232 · lead sponsor · 2025-12-08

Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia PatientsNCT07045142 · lead sponsor · 2025-07-01

Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic AirspacesNCT07066813 · lead sponsor · 2025-06-01

Multimodal AI Predicts High-risk Pathology in Lung Cancer Associated With Cystic AirspacesNCT07820423 · lead sponsor · 2025-05-01

Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in SchizophreniaNCT06673966 · lead sponsor · 2025-01-10

nTMS for Negative Symptom in SchizophreniaNCT06642675 · lead sponsor · 2024-11-22

Multi-omics Study of Early-stage Lung Cancer With Distinct PhenotypesNCT06699979 · lead sponsor · 2024-08-29

Establishing a Clinical Database and Biobank for Schizophrenia：A Cohort StudyNCT06123897 · lead sponsor · 2024-01-01

iTBS for Increased Appetite Induced by AntipsychoticsNCT05783063 · lead sponsor · 2023-08-01

Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical ApplicationsNCT07444463 · lead sponsor · 2027-01-01

NOT_YET_RECRUITING

Temporal Interference Transcranial Alternating Current Stimulation for Major Depressive DisorderNCT07712159 · lead sponsor · 2026-10-10

NOT_YET_RECRUITING

Efficacy and Safety of Individualized Sequential Accelerated Theta Burst Stimulation in Improving Cognitive Function in SchizophreniaNCT07806877 · lead sponsor · 2026-09-30

NOT_YET_RECRUITING

TIS for Improving Cognitive Impairment Associated With SchizophreniaNCT07446478 · lead sponsor · 2026-06-24

AKK Study in Improving Obesity and Metabolic Status in Children and AdolescentsNCT07593170 · lead sponsor · 2026-06-06

NOT_YET_RECRUITING

Neurobiological Mechanisms of Pathological Rumination and Effects of AripiprazoleNCT06937476 · lead sponsor · 2025-05-08

ACTIVE_NOT_RECRUITING

A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study on the Treatment of Depression with Jieyu Chufan CapsulesNCT06749470 · lead sponsor · 2024-12-22

NOT_YET_RECRUITING

Investigating the Insulin Resistance in Individuals With Type 2 DiabetesNCT06428968 · lead sponsor · 2024-09-06

Exploring Sarcopenia in Parkinson's Disease Patients by Combining Serum Biomarker LevelsNCT06511531 · lead sponsor · 2024-08-01

Metformin Treatment on Cognitive Impairment of SchizophreniaNCT05838573 · lead sponsor · 2023-05-08

iTBS on Negative Symptoms and Cognitive Function in SchizophreniaNCT05137158 · lead sponsor · 2022-10-15

iTBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging.NCT05448430 · lead sponsor · 2022-07-15

aiTBS for Relieving NSSI in Depressive PatientsNCT05384405 · lead sponsor · 2022-07-01

Accelerated cTBS on Metabolic Dysfunction in People With SchizophreniaNCT05358899 · lead sponsor · 2022-06-01

A 6-month Study to Evaluate Sulforaphane Effects in PD PatientsNCT05084365 · lead sponsor · 2021-11-28

cTBS on First-episode Drug Naive Patients With SchizophreniaNCT05086133 · lead sponsor · 2021-11-20

Ai Youmian (Love Better Sleep) for People Living With HIVNCT05576844 · lead sponsor · 2021-09-28

A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in SchizophreniaNCT05039489 · lead sponsor · 2021-09-09

Adjunctive Game Intervention for Anhedonia in MDD PatientsNCT04977232 · lead sponsor · 2021-09-09

Resting State Electroencephalogram for Psychotic DisordersNCT05065489 · lead sponsor · 2021-09-01

rTMS on Appetite and Cognitive Function in SchizophreniaNCT04714970 · lead sponsor · 2021-04-20

Effects of MSC Intervention on the Dyadic Mental Health of Lung Cancer Patients and Their CaregiversNCT04795700 · lead sponsor · 2021-03-01

Dyadic Psychological Stress Among Lung Cancer Patient-caregiver DyadsNCT06746948 · lead sponsor · 2021-01-01

Using 18F-FPEB PET to Identify mGLUR5 Availability in Affective DisordersNCT05840861 · lead sponsor · 2020-11-05

The Sensitivity and Specificity of Canine Detection of Parkinson's DiseaseNCT04613531 · lead sponsor · 2020-11-01

A Double-blind, Placebo-controlled Study of Antidepressant Augmentation With AgomelatineNCT04589143 · lead sponsor · 2020-10-01

A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia PatientsNCT04521868 · lead sponsor · 2020-08-31

Intervention Program to Address PTSD in People Living With HIVNCT05588596 · lead sponsor · 2020-05-03

Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental DisordersNCT04218981 · lead sponsor · 2020-01-15

Effect of Short-Term Mindfulness-Based Training For Major Depression Disorder: An Eye-Tracking StudyNCT04071886 · lead sponsor · 2019-09-01

An Eye Tracking Study of Affective Disorder Patients With Suicide RiskNCT03711045 · lead sponsor · 2018-09-01

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic PatientsNCT03451734 · lead sponsor · 2018-01-23

A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar DisorderNCT03379597 · lead sponsor · 2017-11-30

Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic SyndromeNCT03271866 · lead sponsor · 2017-08-28

Mindful Living With Stress for Nurses Caring for HIV/AIDS Patients in ChinaNCT02936310 · lead sponsor · 2017-01-01

A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of SchizophreniaNCT02880462 · lead sponsor · 2016-12-26

The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic SyndromeNCT02093858 · lead sponsor · 2014-04-01

Antipsychotic to Treat Psychosis SyndromeNCT02137616 · lead sponsor · 2012-06-01

A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in SchizophreniaNCT01490567 · lead sponsor · 2011-06-01

The Study of Minocycline for Negative and Cognitive Symptoms in SchizophreniaNCT01493622 · lead sponsor · 2010-06-01

Metformin for Treatment of Antipsychotic-induced DyslipidemiaNCT01778244 · lead sponsor · 2008-11-01

Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in SchizophreniaNCT00859872 · lead sponsor · 2008-08-01

Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective StudyNCT01479400 · lead sponsor · 2007-10-01

Effect of Adiponectin Genetic Polymorphism on Rosiglitazone ResponseNCT00501488 · lead sponsor · 2006-03-01

Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With SchizophreniaNCT00654576 · lead sponsor · 2005-02-01

Identification and Treatment of the Liability to Develop SchizophreniaNCT00305474 · lead sponsor · 2003-12-01

Belimumab After Rituximab in Resistant Primary Juvenile SSNCT06410833 · collaborator · 2024-03-09

Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID RegistryNCT06417502 · collaborator · 2022-04-29

Preoperative Anxiety and Depression Among Older Chinese PatientsNCT07744295 · collaborator · 2026-08-15

NOT_YET_RECRUITING

Sponsor roles

lead sponsor57

collaborator20

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.